Latest industry research report on Preimplantation genetic diagnosis Market. Preimplantation genetic diagnosis (PGD) is a diagnostic technology used with an in-vitro fertilization (IVF) procedure for the genetic profiling of the embryo prior to implantation in the uterus. PGD is intended for use in the selection of embryos without genetic disorders, thereby increasing the chances of the successful pregnancy, and for embryonic-sex selection.
High prevalence of undiagnosed congenital disorders -at the early stage – has created an impending need for PGD testing. PGD is primarily used to diagnose severe disorders such as cancer and other genetic disorders in the embryos before commencing the IVF treatment.Presently, the PGD market is witnessing impressive growth owing to the increasing rates of infertility and a large adoption of IVF technology worldwide.
Get Free Sample Report Of Preimplantation genetic diagnosis Market @ http://www.marketresearchstore.com/report/world-preimplantation-genetic-diagnosis-market-opportunities-and-71700#RequestSample
Another key factor driving the PGD market is rising fertility tourism, especially, in emerging economies. However, the high procedural cost, inadequate reimbursement policies and ethical considerations related to the embryo-based studies are key factors that limit the growth of the global PGD market.
Overcoming the lack of technological awareness, particularly in under-developed economies would be a major challenge for companies to sustain their growth in the global PGD market.
Companies such as Perkin Elmer are largely focusing on the production of PGD testing technologies such as GeneAmp 9700 PCR and FISH Systems. The companies profiled in this report include Abbott Laboratories, Inc., PerkinElmer, Inc., Quest Diagnostics, Inc., Laboratory Corporation of America Holdings, Illumina, Inc., Genesis genetics, Reprogenetics, LLC, Natera, Inc., GeneDx, Inc. and Rubicon Genomics, Inc.
Do Inquiry To Buy Report Of Preimplantation genetic diagnosis Market @ http://www.marketresearchstore.com/report/world-preimplantation-genetic-diagnosis-market-opportunities-and-71700#InquiryForBuying
The Preimplantation Genetic Diagnosis market is segmented based on the technology, applications, end-users, PGD products and by the geography.
Preimplantation genetic diagnosis market by technology
- Polymerase chain reaction (PCR)
- Fluorescence in-situ hybridization (FISH)
- Next generation sequencing (NGS)
- Comparative genomic hybridization (CGH)
Preimplantation genetic diagnosis market by applications
- Gene deletions
- Genetic translocations
- Genetic Inversions
Inheritable genetic disorders
Single gene disorders
- Hereditary Cancer
- Muscular dystrophy
- Fragile X-syndrome
- Cystic fibrosis
- Huntingtons disease
Preimplantation genetic diagnosis market by end-users
- Hospitals/diagnostic centres
- Fertility clinics
- Academic and research institutes
Preimplantation genetic diagnosis market by PGD products
- PGD instruments
- PGD reagents
- PGD software
- PGD accessories (kits)
Preimplantation genetic diagnosis market by geography
- North America
About Market research Store
Market Research Store is a single destination for all the industry, company and country reports. We feature large repository of latest industry reports, leading and niche company profiles, and market statistics released by reputed private publishers and public organizations. Market Research Store is the comprehensive collection of market intelligence products and services available on air. We have market research reports from number of leading publishers and update our collection daily to provide our clients with the instant online access to our database. With access to this database, our clients will be able to benefit from expert insights on global industries, products, and market trends.
3422 SW 15 Street, Suit #8138,
Deerfield Beach, Florida 33442, USA
USA Tel: +1-386-310-3803
GMT Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651